Author(s): Weiner LM, Surana R, Wang S, Weiner LM, Surana R, Wang S, Weiner LM, Surana R, Wang S, Weiner LM, Surana R, Wang S
Abstract Share this page
Abstract Antibodies are important therapeutic agents for cancer. Recently, it has become clear that antibodies possess several clinically relevant mechanisms of action. Many clinically useful antibodies can manipulate tumour-related signalling. In addition, antibodies exhibit various immunomodulatory properties and, by directly activating or inhibiting molecules of the immune system, antibodies can promote the induction of antitumour immune responses. These immunomodulatory properties can form the basis for new cancer treatment strategies.
This article was published in Nat Rev Immunol
and referenced in Immunotherapy: Open Access